会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE WITH MINIMAL INITIAL BURST
    • 用最小初始爆炸物持续释放布可宁的可植入聚合物
    • WO2007139744A2
    • 2007-12-06
    • PCT/US2007/012046
    • 2007-05-18
    • TITAN PHARMACEUTICALS, INC.PATEL, Rajesh, A.BUCALO, Louis, R.
    • PATEL, Rajesh, A.BUCALO, Louis, R.
    • A61K9/06
    • A61K9/0024A61K9/1682
    • The present invention provides compositions, methods, and kits for treatment of pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time, and exhibits minimal initial burst upon subcutaneous implantation. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine. Devices of the invention are washed with ethanol for greater than 30 minutes prior to subcutaneous implantation or have release characteristics of a device that has been washed with ethanol for greater than 30 minutes, such as a low peak to steady state plasma level ratio.
    • 本发明提供用于治疗疼痛的组合物,方法和试剂盒。 本发明提供了一种生物相容性非可矫治的聚合物装置,其通过线性释放动力学连续释放丁丙诺啡以延长时间,并且在皮下植入时表现出最小的初始爆发。 丁丙诺啡通过孔被释放,孔通过其被封装在其中的聚合物基质的表面。 该装置可以皮下给予需要用丁丙诺非连续治疗的个体。 在皮下植入之前,本发明的装置用乙醇洗涤超过30分钟,或者已经用乙醇洗涤超过30分钟的装置(例如低峰值 - 稳态血浆水平比)的释放特性。
    • 5. 发明申请
    • HETEROGENEOUS IMPLANTABLE DEVICES FOR DRUG DELIVERY
    • 用于药物递送的异质可植入装置
    • WO2011116132A1
    • 2011-09-22
    • PCT/US2011/028727
    • 2011-03-16
    • TITAN PHARMACEUTICALS, INC.PATEL, Rajesh, A.BHONSLE, Sunil, R.
    • PATEL, Rajesh, A.BHONSLE, Sunil, R.
    • A61K9/22
    • A61K9/0024A61K9/2086A61K9/2886A61K31/198A61K31/4045A61K31/485A61K45/06A61K47/32
    • The present invention comprises compositions, methods and kits for delivering drugs. The invention provides an implantable device for delivery of a pharmaceutical substance to a patient, comprising a core comprising a core polymeric material optionally containing a core pharmaceutical substance, surrounded by a first layer comprising a first-layer pharmaceutical substance and a first-layer polymeric material, optionally surrounded by one or more additional layers comprising an additional pharmaceutical substance and an additional polymeric material, where the core, first, and optional additional polymeric materials may be the same or different, and where the optional core pharmaceutical substance, first-layer pharmaceutical substance, and optional additional pharmaceutical substances are the same or different. Implantation of the device allows a controlled release of drug for an extended period of time. The device may be implanted subcutaneously in an individual in need of continuous treatment with a drug.
    • 本发明包括用于递送药物的组合物,方法和试剂盒。 本发明提供了一种用于将药物物质递送到患者的可植入装置,其包括芯,其包含任选地含有核心药物物质的核心聚合物材料,被包含第一层药物物质的第一层和第一层聚合物材料 ,任选被包含另外的药物物质和另外的聚合物材料的一个或多个另外的层包围,其中芯,第一和任选的另外的聚合物材料可以相同或不同,并且其中任选的核心药物物质,第一层药物 物质和任选的另外的药物相同或不同。 装置的植入允许药物长时间控制释放。 该装置可以皮下植入需要用药物连续治疗的个体中。
    • 7. 发明申请
    • IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE WITH MINIMAL INITIAL BURST
    • 用最小初始爆炸物持续释放布可宁的可植入聚合物
    • WO2007139744A3
    • 2008-11-06
    • PCT/US2007012046
    • 2007-05-18
    • TITAN PHARMACEUTICALS INCPATEL RAJESH ABUCALO LOUIS R
    • PATEL RAJESH ABUCALO LOUIS R
    • A61K9/06
    • A61K9/0024A61K9/1682
    • The present invention provides compositions, methods, and kits for treatment of pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time, and exhibits minimal initial burst upon subcutaneous implantation. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine. Devices of the invention are washed with ethanol for greater than 30 minutes prior to subcutaneous implantation or have release characteristics of a device that has been washed with ethanol for greater than 30 minutes, such as a low peak to steady state plasma level ratio.
    • 本发明提供用于治疗疼痛的组合物,方法和试剂盒。 本发明提供了一种生物相容的非可溶性聚合物装置,其通过延长的时间段以大致线性释放动力学连续释放丁丙诺啡,并且在皮下植入时显示出最小的初始爆发。 丁丙诺啡通过孔被释放,孔通过其被封装在其中的聚合物基质的表面。 该装置可以皮下给予需要用丁丙诺非连续治疗的个体。 本发明的装置在皮下植入之前用乙醇洗涤超过30分钟,或者已经用乙醇洗涤超过30分钟的装置的释放特性,例如低峰 - 稳态血浆水平比。